Molly Melhem

Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia.

Targeting NF-kappaB in Waldenstrom macroglobulinemia.

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Novel therapeutic agents in Waldenström's macroglobulinemia.

Role of proteasome inhibition in Waldenström's macroglobulinemia.

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.